Fairtree Asset Management »

United Therapeutics Corporation shares owned by Fairtree Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Fairtree Asset Management from 13F filings

Historical chart of Fairtree Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Fairtree Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Fairtree Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $802k 1.9k 419.21
2025-06-30 $664k 2.3k 287.35
2025-03-31 $564k 1.8k 308.27

More positions owned by Fairtree Asset Management

Kaspi Kz Jsc Sponsored Ads (KSPI)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Us Treas Bd Etf (GOVT)
Jd.com Spon Ads Cl A (JD)
Amazon (AMZN)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Alibaba Group Hldg Sponsored Ads (BABA)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Qualcomm (QCOM)
Applied Materials (AMAT)
Zoetis Cl A (ZTS)

View all positions for Fairtree Asset Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation